How are BRKR straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the BRKR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 52.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$533.02 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a BRKR straddle?

The breakeven for the BRKR straddle priced on this page is roughly $37.05 and $47.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BRKR market-implied 1-standard-deviation expected move is approximately 14.97%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current BRKR implied volatility affect this straddle?

BRKR ATM IV is at 52.20% with IV rank near 28.07%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

BRKR Straddle Strategy

BRKR (Bruker Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery.

BRKR (Bruker Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $6.67B, a beta of 1.12 versus the broader market, a 52-week range of 28.53-56.22, average daily share volume of 2.1M, a public-listing history dating back to 2000, approximately 11K full-time employees. These structural characteristics shape how BRKR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.12 places BRKR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. BRKR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a straddle on BRKR?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current BRKR snapshot

As of May 15, 2026, spot at $42.83, ATM IV 52.20%, IV rank 28.07%, expected move 14.97%. The straddle on BRKR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this straddle structure on BRKR specifically: BRKR IV at 52.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a BRKR straddle, with a market-implied 1-standard-deviation move of approximately 14.97% (roughly $6.41 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BRKR expiries trade a higher absolute premium for lower per-day decay. Position sizing on BRKR should anchor to the underlying notional of $42.83 per share and to the trader's directional view on BRKR stock.

BRKR straddle setup

The BRKR straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BRKR near $42.83, the first option leg uses a $42.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BRKR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BRKR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$42.50	$2.98
Buy 1	Put	$42.50	$2.48

BRKR straddle risk and reward

Net Premium / Debit: -$545.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$533.02
Breakeven(s): $37.05, $47.95
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

BRKR straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on BRKR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$3,704.00
$9.48	-77.9%	+$2,757.12
$18.95	-55.8%	+$1,810.23
$28.42	-33.7%	+$863.35
$37.89	-11.5%	-$83.54
$47.35	+10.6%	-$59.58
$56.82	+32.7%	+$887.31
$66.29	+54.8%	+$1,834.19
$75.76	+76.9%	+$2,781.08
$85.23	+99.0%	+$3,727.96

When traders use straddle on BRKR

Straddles on BRKR are pure-volatility plays that profit from large moves in either direction; traders typically buy BRKR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

BRKR thesis for this straddle

The market-implied 1-standard-deviation range for BRKR extends from approximately $36.42 on the downside to $49.24 on the upside. A BRKR long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current BRKR IV rank near 28.07% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BRKR at 52.20%. As a Healthcare name, BRKR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BRKR-specific events.

BRKR straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BRKR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BRKR alongside the broader basket even when BRKR-specific fundamentals are unchanged. Always rebuild the position from current BRKR chain quotes before placing a trade.

Frequently asked questions

What is a straddle on BRKR?: A straddle on BRKR is the straddle strategy applied to BRKR (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With BRKR stock trading near $42.83, the strikes shown on this page are snapped to the nearest listed BRKR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BRKR straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the BRKR straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 52.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$533.02 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BRKR straddle?: The breakeven for the BRKR straddle priced on this page is roughly $37.05 and $47.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BRKR market-implied 1-standard-deviation expected move is approximately 14.97%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on BRKR?: Straddles on BRKR are pure-volatility plays that profit from large moves in either direction; traders typically buy BRKR straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current BRKR implied volatility affect this straddle?: BRKR ATM IV is at 52.20% with IV rank near 28.07%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.